Advanced Search

Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2015 December;67(4) > Minerva Urologica e Nefrologica 2015 December;67(4):303-15

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536

Frequency: Bi-Monthly

ISSN 0393-2249

Online ISSN 1827-1758

 

Minerva Urologica e Nefrologica 2015 December;67(4):303-15

ADVANCED TOPICS IN THE TREATMENT OF LARGE RENAL STONES 

    REVIEWS

Safety of percutaneous nephrolithotomy in patients on antithrombotic therapy: a review of guidelines and recommendations

Siev M. 1, Motamedinia P. 1, Leavitt D. A. 1, Keheila M. 1, Kiewe R. 2, Okeke Z. 1

1 The Arthur Smith Institute for Urology, Hofstra North Shore, Long Island Jewish School of Medicine, New Hyde Park, NY, USA;
2 Department of Cardiology, Hofstra North Shore, Long Island Jewish School of Medicine, New Hyde Park, NY, USA

With the expanding use of chronic antithrombotic medical management for coronary artery disease, surgeons face the growing challenge of balancing the risks of postoperative bleeding against perioperative cardiovascular events. Percutaneous nephrolithotomy (PCNL) carries a risk of bleeding and the need for transfusion at baseline, which is further increased in patients on anticoagulation and antiplatelet therapy. Broad perioperative recommendations for risk stratification and antithrombotic management exist for surgical patients, however, they are less clear in those undergoing PCNL. In this review we appraise available literature, guidelines and opinions and present a consensus statement for antithrombotic management in patients undergoing PCNL.

language: English


FULL TEXT  REPRINTS

top of page